This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies

LAST CHANCE: REGISTER BY MAY 20 TO SAVE UP TO $300

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
June 14-16, 2022
Delivered as a Hybrid EventIntercontinental Mark Hopkins Hotel, San Francisco, California
Book Now
Menu
Book Now

Kate Rochlin
Chief Operating Officer at IN8bio, USA

Agenda Sessions

  • Maintaining Both Innate Killing & Specific Targeting of Heterogeneous Tumours with Chemotherapy-Resistant Chlorotoxin CAR-T Cells

    , 5:15pm
    View Session

Speakers at this event

Prev
Next
John Rossi
Head of Translational Research
CERo Therapeutics, USA

See Kate Speak

Book Now